Wechselwirkungen · Binocrit
Binocrit 1 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 2 000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 3 000 IU/0.3 mL solution for injection in a pre-filled syringe Binocrit 4 000 IU/0.4 mL solution for injection in a pre-filled syringe Binocrit 5 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 6 000 IU/0.6 mL solution for injection in a pre-filled syringe Binocrit 7 000 IU/0.7 mL solution for injection in a pre-filled syringe Binocrit 8 000 IU/0.8 mL solution for injection in a pre-filled syringe Binocrit 9 000 IU/0.9 mL solution for injection in a pre-filled syringe Binocrit 10 000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 20 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 30 000 IU/0.75 mL solution for injection in a pre-filled syringe Binocrit 40 000 IU/1 mL solution for injection in a pre-filled syringe · Abschnitt 4.5 · PDF-Seite 15
HOS-208640 · Präparat HOS-154153
Since cyclosporin is bound by RBCs there is potential for a medicinal product interaction. If epoetin alfa is given concomitantly with cyclosporin, blood levels of cyclosporin should be monitored and the dose of cyclosporin adjusted as the haematocrit rises.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-11T12:00:00Z · SHA-256 32f7055c1c48e53a5b1fccb28344f59f964b4cbd18912244c1595c84d77498b9 · Passage 222922b8a8b8bd8f1f2a977004e6164db8fb23bc83e8ac76d5ee72eca8348131 · Zeichen 210–468 im Abschnitt